Primary Site >> Stomach Cancer
Gene >> NRG1
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. PMID: 10535875 |
Ref: A Helicobacter pylori restriction endonuclease-replacing gene, hrgA, is associated with gastric cancer in Asian strains. PMID: 11956101 |
Ref: The Helicobacter pylori restriction endonuclease-replacing gene, hrgA, and clinical outcome: comparison of East Asia and Western countries. PMID: 15481336 |
Ref: Canonical WNT signaling pathway and human AREG. PMID: 16685431 |
Ref: A simple multiplex PCR assay for diagnosing virulent Helicobacter pylori infection in human gastric biopsy specimens from subjects with gastric carcinoma and other gastro-duodenal diseases. PMID: 17850305 |
Ref: Prognostic significance of genotyping Helicobacter pylori infection in patients in younger age groups with gastric cancer. PMID: 18424576 Ref: Association of Helicobacter pylori restriction endonuclease-replacing gene, hrgA with overt gastrointestinal diseases. PMID: 18852951 Ref: Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. PMID: 19091131 |
Ref: Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer. PMID: 20104227 |
Ref: Evaluation of the clinical relevance of hrgA gene in patients with Helicobacter pylori infection. PMID: 22251550 |
Ref: Overexpression of NRG1 promotes progression of gastric cancer by regulating the self-renewal of cancer stem cells. PMID: 25381017 Ref: Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. PMID: 25583476 |
Ref: Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand. PMID: 29084246 |
Ref: Clinical significance of overexpression of NRG1 and its receptors, HER3 and HER4, in gastric cancer patients. PMID: 28573357 Ref: The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition. PMID: 29535422 |